Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2

Clinical and Vaccine Immunology

Volumn 15, Issue 3, 2008, Pages 439-446

  Bernardo, Lidice ^a   Izquierdo, Alienys ^a   Prado, Irina ^a   Rosario, Delfina ^a   Alvarez, Mayling ^a   Santana, Emidalys ^a   Castro, Jorge ^b   Martínez, Rafael ^b   Rodríguez, Rosmari ^a   Morier, Luis ^a   Guillén, Gerardo ^a   Guzmán, María G ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; ASIAN; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DENGUE VIRUS 2; GENOTYPE; HUMORAL IMMUNITY; IMMUNE RESPONSE; MACACA; MONKEY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY INFECTION; TISSUE CULTURE; UNITED STATES; VIREMIA; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; WESTERN BLOTTING; AEDES; ANIMAL; ASIA; BLOOD; CELL LINE; CERCOPITHECUS; CLASSIFICATION; COMPARATIVE STUDY; GENETICS; HAMSTER; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOUSE; PATHOGENICITY; PATHOPHYSIOLOGY; VERO CELL; VIROLOGY; WESTERN HEMISPHERE;

AEDES; AMERICAS; ANIMALS; ANTIBODIES, VIRAL; ASIA; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; DENGUE; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; GENOTYPE; HUMANS; IMMUNOGLOBULIN M; MACACA FASCICULARIS; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VERO CELLS; VIRUS REPLICATION;

EID: 42049085948     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00208-07     Document Type: Article

References (47)

1. Alvarez, M., R. Rodriguez-Roche, L. Bernardo, L. Morier, and M. G. Guzman. 2005. Improved dengue virus plaque formation on BHK21 and LLCMK2 cells: evaluation of some factors. Dengue Bull. 29:1-9.
2. Armstrong, P. M., and R. Rico-Hesse. 2001. Differential susceptibility of Aedes aegypti to infection by the American and Southeast Asian genotypes of dengue type 2 virus. Vector Borne Zoonotic Dis. 1:159-168.
3. Bernardo, L., A. Yndart, S. Vazquez, L. Morier, and M. G. Guzman. 2005. Antibody responses to Asian and American genotypes of dengue 2 virus in immunized mice. Clin. Diagn. Lab. Immunol. 12:361-362.
4. Bernardo, L., L. Hermida, J. Martin, M. Alvarez, I. Prado, C. López, R. Martínez, R. Rodríguez-Roche, A. Zulueta, L. Lazo, D. Rosario, G. Guillén, and M. G. Gúzman. Anamnestic antibody response after viral challenge in monkeys immunized with dengue 2 recombinant fusion proteins. Arch. Virol., in press.
5. Blaney, J. E., Jr., C. T. Hanson, K. A. Hanley, B. R. Murphy, and S. S. Whitehead. 2004. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2. BMC Infect. Dis. 4:39.
6. Bravo, J. R., M. G. Guzman, and G. P. Kouri. 1987. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans. R. Soc. Trop. Med. Hyg. 81:816-820.
7. Chen, Y., T. Maguire, and R. M. Marks. 1996. Demonstration of binding of dengue virus envelope protein to target cells. J. Virol. 70:8765-8772.
8. Churdboonchart, V., N. Bhamarapravati, S. Peampramprecha, and S. Sirinavin. 1991. Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 44:481-493.
9. Clarke, D. H., and J. Casals. 1958. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am. J. Trop. Med. Hyg. 7:561-573.
10. Cologna, R., and R. Rico-Hesse. 2003. American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J. Virol. 77:3929-3938.
11. Falconar, A. K. 1999. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins. Arch. Virol. 144:2313-2330.
12. Gubler, D. J. 1998. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11:480-496.
13. Guzman, M. G., M. Alvarez, R. Rodriguez, D. Rosario, S. Vazquez, L. Valdes, M. V. Cabrera, and G. Kouri. 1999. Fatal dengue hemorrhagic fever in Cuba, 1997. Int. J. Infect. Dis. 3:130-135.
14. Guzman, M. G., V. Deubel, J. L. Pelegrino, D. Rosario, M. Marrero, C. Sariol, and G. Kouri. 1995. Partial nucleotide and amino acid sequences of the envelope and the envelope/nonstructural protein-1 gene junction of four dengue-2 virus strains isolated during the 1981 Cuban epidemic. Am. J. Trop. Med. Hyg. 52:241-246.
15. Guzman, M. G., and G. Kouri. 2002. Dengue: an update. Lancet Infect. Dis. 2:33-42.
16. Halstead, S. B. 1970. Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J. Biol. Med. 42:350-362.
17. Halstead, S. B., J. Casals, H. Shotwell, and N. Palumbo. 1973. Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections. Am. J. Trop. Med. Hyg. 22:365-374.
18. Halstead, S. B., and N. E. Palumbo. 1973. Studies on the immunization of monkeys against dengue. II. Protection following inoculation of combinations of viruses. Am. J. Trop. Med. Hyg. 22:375-381.
19. Halstead, S. B., H. Shotwell, and J. Casals. 1973. Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. J. Infect. Dis. 128:7-14.
20. Halstead, S. B., H. Shotwell, and J. Casals. 1973. Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. J. Infect. Dis. 128:15-22.
21. Halstead, S. B., and P. Simasthien. 1970. Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host. Yale J. Biol. Med. 42:276-292.
22. Henchal, E. A., M. K. Gentry, J. M. McCown, and W. E. Brandt. 1982. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am. J. Trop. Med. Hyg. 31:830-836.
23. Hermida, L., L. Bernardo, J. Martin, M. Alvarez, I. Prado, C. Lopez, L. Sierra Bde, R. Martinez, R. Rodriguez, A. Zulueta, A. B. Perez, L. Lazo, D. Rosario, G. Guillen, and M. G. Guzman. 2006. A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates. Vaccine 24:3165-3171.
24. Innis, B. 1997. Antibody responses to dengue virus infection, p. 221-243. In D. Gubler and G. Kuno (ed.), Dengue and dengue haemorrhagic fever. CAB International, New York, NY.
25. Janeway, C., and P. Travers. 1994. Host defense against infection, 1st ed. Blackwell Scientific Publications, London, United Kingdom.
26. Kanesa-thasan, N., W. Sun, G. Kim-Ahn, S. Van Albert, J. R. Putnak, A. King, B. Raengsakulsrach, H. Christ-Schmidt, K. Gilson, J. M. Zahradnik, D. W. Vaughn, B. L. Innis, J. F. Saluzzo, and C. H. Hoke, Jr. 2001. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine 19:3179-3188.
27. Kochel, T. J., D. M. Watts, A. S. Gozalo, D. F. Ewing, K. R. Porter, and K. L. Russell. 2005. Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys. J. Infect. Dis. 191:1000-1004.
28. Kouri, G., P. Mas, M. G. Guzman, M. Soler, A. Goyenechea, and L. Morier. 1983. Dengue hemorrhagic fever in Cuba, 1981: rapid diagnosis of the etiologic agent. Bull. Pan Am. Health Organ. 17:126-132.
29. Kouri, G. P., M. G. Guzman, and J. R. Bravo. 1987. Why dengue haemorrhagic fever in Cuba? 2. An integral analysis. Trans. R. Soc. Trop. Med. Hyg. 81:821-823.
30. Laemmli, U. K. 1970. Cleavage of structural protein during assembly of the head of bacteriphage T4. Nature 227:680-685.
31. Lanciotti, R. S., C. H. Calisher, D. J. Gubler, G. J. Chang, and A. V. Vorndam. 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 30:545-551.
32. Leitmeyer, K. C., D. W. Vaughn, D. M. Watts, R. Salas, I. Villalobos de Chacon, C. Ramos, and R. Rico Hesse. 1999. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73:4738-4747.
33. Monath, T. P., G. A. Myers, R. A. Beck, M. Knauber, K. Scappaticci, T. Pullano, W. Tad Archambault, J. Catalan, C. Miller, Z. X. Zhang, S. Shin, K. Pugachev, K. Draper, I. S. Levenbook, and F. Guirakhoo. 2005. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys. Biologicals 33:131-144.
34. Morens, D. M., S. B. Halstead, P. M. Repik, R. Putvatana, and N. Raybourne. 1985. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J. Clin. Microbiol. 22:250-254.
35. Proutski, V., E. A. Gould, and E. C. Holmes. 1997. Secondary structure of the 3′ untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res. 25:1194-1202.
36. Pryor, M. J., J. M. Carr, H. Hocking, A. D. Davidson, P. Li, and P. J. Wright. 2001. Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein. Am. J. Trop. Med. Hyg. 65:427-434.
37. Pupo Antunez, M., H. Rodriguez, S. Vazquez, J. C. Vilaseca, M. Alvarez, A. Otero, and G. Guzman. 1997. Monoclonal antibodies raised to the dengue-2 virus (Cuban: A15 strain) which recognize viral structural proteins. Hybridoma 16:347-353.
38. Rico Hesse, R., L. M. Harrison, R. A. Salas, D. Tovar, A. Nisalak, C. Ramos, J. Boshell, M. T. de Mesa, R. M. Nogueira, and A. T. da Rosa. 1997. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230:244-251.
39. Rodriguez-Roche, R., M. Alvarez, M. G. Guzman, L. Morier, and G. Kouri. 2000. Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells. J. Clin. Microbiol. 38:3508-3510.
40. Roehrig, J. T., R. A. Bolin, and R. G. Kelly. 1998. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246:317-328.
41. Rosario, D., M. Alvarez, J. Diaz, R. Contreras, R. Rodriguez, S. Vazquez, and M. G. Guzman. 1998. Polymerase chain reaction for rapid detection and serotyping of dengue virus in clinical samples. Rev. Panam. Salud Publica 4:1-5.
42. Rosen, L. 1986. The pathogenesis of dengue haemorrhagic fever. A critical appraisal of current hypotheses. S. Afr. Med. J. Suppl. 1986:40-42.
43. Sabin, A. B. 1952. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1:30-50.
44. Shi, Y., K. Agematsu, H. D. Ochs, and K. Sugane. 2003. Funtional analysis of human memory B-cell subpopulations: IgD+D27+B cells are crucial in secondary immune response by producing high affinity IgM. Clin. Immunol. 108:128-137.
45. Towbin, H., Staehelin, T., and J. Golden. 1979. Electrophoretic transfer of protein from polyacrylamide gel to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
46. Zivna, I., S. Green, D. W. Vaughn, S. Kalayanarooj, H. A. Stephens, D. Chandanayingyong, A. Nisalak, F. A. Ennis, and A. L. Rothman. 2002. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J. Immunol. 168:5959-5965.
47. Zivny, J., M. DeFronzo, W. Jarry, J. Jameson, J. Cruz, F. A. Ennis, and A. L. Rothman. 1999. Partial agonist effect influences the CTL response to a heterologous dengue virus serotype. J. Immunol. 163:2754-2760.